Clin2
NCT07803185Possibly a fitRecruiting

Emotional eating and anhedonia with weight loss medications

ObesityEmotional EatingAnhedonia

Part of Brain & nervous system, Hormones & metabolism clinical trials.

This study looks at how GLP-1 weight loss medications affect emotional eating (eating in response to feelings) and anhedonia (loss of interest or pleasure). If you're starting one of these drugs for weight loss, your participation may help understand these side effects.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older
  • You recently started a GLP-1 medication for weight loss (not for diabetes or other reasons)
  • You can read and understand Turkish and answer questionnaires
  • You commit to two visits: one now and one after 6 months
  • You are mentally able to fill out the questionnaires

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06174389Recruiting
Weight loss study: diet, appetite and body changes

This study looks at how diet, appetite, and body changes work together during weight loss. It's designed for people with a BMI of 30 to 50 who want to lose weight and are not taking certain medications or have certain health conditions.

Seattle, Washington
NCT07789223Recruiting
Weight management study with natural supplements

This study tests a natural supplement (elénzia CONTROL®) to help with weight loss and metabolic health. Researchers want to see if it works for people who have never used GLP-1 medications or who have stopped using them.

Redditch, West Midlands
NCT07815678Recruiting· Phase 1/Phase 2
Safety study of an oral medication in people with normal or higher weight

This study tests a new oral medication called ACCG-2671 to see how safe it is and how your body handles it. It's an early-stage trial, so the main focus is on safety and tolerability. The study has different parts: one for people with normal weight and one for people with higher weight who are already taking a GLP-1 injection for weight loss.

Cypress, California
NCT07854886Not yet recruiting
Brain response to a diabetes drug in healthy weight and obesity

This study looks at how a medication that mimics a natural gut hormone affects brain activity related to appetite in people with healthy weight or obesity. It may help researchers find new ways to treat obesity.

Copenhagen
NCT07339423Recruiting· Phase 3
A study of a new medicine for weight loss

This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.

Miramar, Florida
NCT07793019Recruiting· Phase 1
Weight loss and safety study in overweight adults

This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.

Beijing, Beijing Municipality

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.